I don't think we have a floor until an institutional is on board. We do have an end date though so vc capital may have a look. I have discounted aurora. It's a bonus when if it happens. Chk1 will.pass p1 end 2017. 10m milestone guess. P2 end 2018 20m milestone when dnai will on licence it. And we will get a cut. Tyk2 is interesting. It's a variable thermostat. Cancer drugs it's maximum dose before side effects. Autoimmune it's getting the temperature just right. Just the right amount which depends on the disease and the patient. Which is going to take longer. More compounds. More preclinical. More trials. The good news is. Currently incurable diseases. As big as cancer market. Lifelong medicines. And despite the billions spent we appear to have the best in class molecules. So short term who knows. But 2 years I'm expecting full value and in the meantime a poacher may see the same. I personally think 2 big pharma are looking at tyk2 atm. But no hard facts just reading between the lines. Gla
my understanding - until the first payment it is made by ProNai and the Clinical Trial has been transferred TOTALLY to USA; CK1 licence it has not been executed and as such could be said that the the procees can be classified as "SALE AGREED" ..... the next step could be SOLD or "BACK into the MARKET"
AND in both cases i believe it is great news,
1) SOLD because = cash in the bank 2) FOR SALE -- the trial has progressed in the mean time and the value may be higher than what was written in September RNS
Mang - Ok, I read the RNS again. There are a couple of paragraphs that could interpenetrated that, especially this:
ProNAi is in a strong position to further the development of PNT737 and plans to expand its development into the United States and with broader clinical studies. We look forward to reporting on their progress."
But why not say it in plain English? Also, it isn't our compound anymore, any good news from the trials will affect the ProNai SP not SAR's? Unless it generates a heavy milestone payment, I can't see it rising more than a couple of points.
But... what do I know. Ramp away... DYOR, BOOM and all that other Friday rampathon stuff.
I used to be a shorter by trade. If you sell 10 times nms. several times at lunchtime (supposedly quietest time and most inexperienced MMs on) its to influence the price. particularly when its sitting on some key MAs. someone has a naked short on IMHO and I think it will cost them 5 grand to close it atm. just an observation. quite happy with shorters. wish more whingers would put their money where their mouth is.
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.